Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$3.50
-$0.15-4.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 82.51% | 71.65% | 57.90% | 35.24% | 51.30% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 61.58% | 30.61% | 34.61% | 25.73% | 65.64% |
| Operating Income | -61.58% | -30.61% | -34.61% | -25.73% | -65.64% |
| Income Before Tax | -42.43% | -38.71% | -61.08% | -46.58% | -121.23% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -42.43% | -38.71% | -61.08% | -46.58% | -121.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -42.43% | -38.71% | -61.08% | -46.58% | -121.23% |
| EBIT | -61.58% | -30.61% | -34.61% | -25.73% | -65.64% |
| EBITDA | -61.71% | -30.67% | -34.66% | -25.75% | -65.72% |
| EPS Basic | 16.04% | -5.22% | -31.37% | -14.10% | -57.93% |
| Normalized Basic EPS | 18.35% | -2.09% | -31.97% | -13.25% | -33.67% |
| EPS Diluted | 14.07% | -7.34% | -31.37% | -14.10% | -57.93% |
| Normalized Diluted EPS | 18.35% | -2.09% | -31.97% | -13.25% | -33.67% |
| Average Basic Shares Outstanding | 148.38% | 53.86% | 22.71% | 29.77% | 38.15% |
| Average Diluted Shares Outstanding | 148.38% | 53.86% | 22.71% | 29.77% | 38.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |